Mark Klausner

Oxford Immunotec appointed Mark Klausner to its board of directors. He will also become a member of the board’s audit committee and nominating committee. 

Klausner is the co-founder and managing partner of Westwicke Partners, a capital markets advisory and investor relations firm focused on the healthcare industry. Prior to co-founding Westwicke Partners in 2006, he was a managing director in the Equity Capital Markets group at Wachovia, now Wells Fargo, from 2004 to 2006.